All lobbying filings

HANCE SCARBOROUGH

HANCE SCARBOROUGH filed a Q4 report for ALLIANCE FOR PHARMACY COMPOUNDING on January 20, 2026, reporting $50,000 in lobbying income.

Lobbying for ALLIANCE FOR PHARMACY COMPOUNDING · Non-profit association promoting the practice of pharmacy compounding

All filings by HANCE SCARBOROUGH · Everything ALLIANCE FOR PHARMACY COMPOUNDING has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Texas

Official filing document

Lobbyists on this filing 3

ROBERT DAVID PORE

Previously held: Legislative Director, Cong. Jim Turner
MICHAEL TOMBERLIN

Previously held: Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep. Louie Gohmert
THERESA REED

Previously held: Leg. Director for Multiple Members

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Pharmacy

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2026 Appropriations. Drug Shortages

Budget/Appropriations

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2026 Appropriations.

Health Issues

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2026 Appropriations. Drug Shortages

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.